S. Moss

Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity.

M. Dawson, S. Stanway, S. Boakes, 2020, Bioorganic & medicinal chemistry letters.

Influence of Lipophilicity on the Antibacterial Activity of Polymyxin Derivatives and on Their Ability to Act as Potentiators of Rifampicin.

M. Dawson, S. Stanway, S. Boakes, 2021, ACS infectious diseases.

Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206.

M. Dawson, S. Stanway, S. Boakes, 2019, ACS infectious diseases.